Cytotoxic effect of laxaphycins A and B on human lymphoblastic cells (CCRF-CEM) using digitised videomicrofluorometry

In Vivo

Volumn 19, Issue 3, 2005, Pages 577-582

  Gbankoto, Adam ^a,b   Vigo, Jean ^a   Dramane, Karim ^b   Banaigs, Bernard ^a   Aina, Eustache ^b   Salmon, Jean Marie ^a  

^a UNIVERSITÉ DE PERPIGNAN   (France)

^b UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

CCRF CEm living cells; Cell cycle; Cytotoxicity; Laxaphycins; Multiparametric analysis; Videomicrofluorometry

Indexed keywords

CELL NUCLEUS DNA; CYTOTOXIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); HOE 33342; LAXAPHYCIN A; LAXAPHYCIN B; PEPTIDE DERIVATIVE; RHODAMINE 123; UNCLASSIFIED DRUG;

ARTICLE; CELL LABELING; CELL MEMBRANE; CELL STRAIN; CELL SUBPOPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOBLAST; MICROFLUOROMETRY; MITOCHONDRION; MULTIDRUG RESISTANCE; POLYPLOIDY; STRAIN DIFFERENCE;

EID: 17644371311     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Frankmölle WP, Larsen LK, Caplan FR, Patterson GML, Knübel G, Levine IA and Moore RE: Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. I. Isolation and biological properties. J Antibiotics 45: 1451-1457, 1992.
2. Bonnard I, Rolland M, Francisco C and Banaigs B: Total structure and biological properties of Laxaphycins A and B, cyclic lipopeptides from the marine cyanobacterium Lyngbya majuscula. Lett Peptide Sci 4: 289-292, 1997.
3. Frankmölle WP, Knübel G, Moore RE and Patterson GML: Antifungal cyclic peptides from the terrestrial blue-green alga Anabaena laxa. II. Structures of Laxaphycins A, B, D and E. J Antibiotics 45: 1458-1466, 1992.
4. Salmon JM, Lautier D, Lahmy S, Vigo J and Viallet P: Multiwavelength videomicrofluorometry and multiparametric analysis: application to the detection of multidrug-resistance in single living cells. J Cell Pharmacol 3: 86-94, 1992.
5. Rocchi E, Vigo J, Viallet P and Salmon JM: Multiwavelength videomicrofluorometric study of some human leukemic lymphoblasts. Effect of adriamycin on some biological parameters. Anticancer Res 18: 1091-1098, 1998.
6. Rocchi E, Vigo J, Viallet P, Bonnard I, Banaigs B and Salmon JM: Multiwavelength videomicroflorometric study of cytotoxic properties of a marine peptide, Didemnin B, using adriamycin as reference compound. Anticancer Res 19: 3559-3558, 1999.
7. Lahmy S, Viallet P and Salmon JM: Is reduced accumulation of Hoechst 33342 in multidrug resistant cells related to P-glycoprotein activity? Cytometry 19: 126-133, 1995.
8. Latt S and Stetten G: Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem 24: 24-33, 1976.
9. Johnson LV, Walsh ML and Chen LB: Localization of mitochondria in living cells with Rhodamine 123. Proc Natl Sci USA 77 990-994, 1980.
10. Darzynkiewicz Z, Staiano-Coico L and Melamed MR: Increased mitochondrial uptake of Rhodamine 123 during lymphocyte stimulation. Proc Natl Acad Sci USA 78: 2383-2387, 1981.
11. Canitrot Y, Lautier D, Lahmy S, Vigo J, Viallet P and Salmon JM: Nile Red labeling of single living cells for contour delineation to quantify and evaluate the distribution of Rhodamine 123 with fluorescence image cytometry. J Histochem Cytochem 14: 1785-1793, 1993.
12. Beck WT, Mueller JC and Tanzer LR: Altered surface membrane glycoprotein in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39: 2070-2076, 1979.
13. Beck WT, Cirtain MC, Look AT and Ashum RA: Reversal of vinca alkaloid-resistance but not multidrug resistance in human leukemia cells by verapamil. Cancer Res 46: 778-784, 1986.
14. Danks M, Schmidt CA, Cirtain MC, Parker-Suttle D and Beck WT: Altered catalytic activity of DNA cleavage by topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry 27: 8861-8869, 1988.
15. Danks D, Schmidt CA, Deneka DA and Beck WT: Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide Cancer Commun 1: 101-109, 1989.
16. Vigo J, Salmon JM, Lahmy S and Viallet P: Fluorescence image cytometry/from quantitative to qualitative measurement. Anal Cell Pathol 3: 145-165, 1991.
17. Vigo J, Viallet P and Salmon JM: Quantitative videomicrofluorometry. Empirical methods for the individual determination of threshold levels of fluorescent objects. Application to living lymphoblastoid cell lines. Optical Biopsies Microsc Techn SPIE 3197 194-204, 1997.
18. Roca J, Ishida R, Berger JM, Andoh T and Wang JC: Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci USA 91: 1781-1785, 1994.
19. Ishida R, Sato M, Narita T, Utsumi KR, Nishimoto T, Morita T, Nagata H and Andoh T: Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol 126: 1341-1351, 1994.